Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Limiting Myeloma Treatment Side Effects

Limiting Myeloma Treatment Side Effects

In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Noopur Raje discuss ways to limit the side effects of treatment for myeloma with Andrew Schorr from Patient Power. Dr. Raje states that the goal is not just to live longer, but to live longer well. Because every patient experiences different side effects from the treatment of the disease, Dr. Raje says the key is communication with your medical team, including nurses. Listen for more tips on managing side effects of myeloma treatment.

Related Videos

Amifostine for Multiple Myeloma with Dr. William Bensinger

Dr. William Bensinger shares the results of a clinical study that was presented at the 54th ASH Annual Meeting and Exposition. For some time, Dr. Bensinger has been interested in the use of amifostine, a drug which has been around for over 35 years and has been used to help protect patients from the toxicity of various treatments. Dr. Bensinger wanted to find out if amifostine could help protect patients from the toxicity of higher-dose melphalan treatments. The study found that who took amfostine were able to tolerate the higher doses of melphalan and also experience a higher response rate than those who took just the standard dose of melphalan.

Using Kyphoplasty to Help Relieve Myeloma Back Pain

Is the jury still out on the use of kyphoplasty to treat myeloma back pain? In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger describes the kyphoplasty procedure and how it stabilizes the vertebra to deliver pain relief. In this video he takes a question from a who was told that kyphoplasty should not be used in the lower back. Dr. Bensinger explains that is effective in the lower back, and tells what type of doctors typically perform the procedure.

Treating Multiple Myeloma with Bisphosphonates

In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. Noopur Raje discusses treating myeloma with bisphosphonates with Andrew Schorr from Patient Power. Dr. Noopur Raje advocates the use of bisphosphonates in treating symptomatic myeloma, and explains how they work on the accessory cells which surround myeloma cells. She discusses the side effects related to the toxicities of bisphosphonates such as osteonecrosis of the jaw (ONJ). Current guidelines suggest bisphosphonates treatment for up to two years. Dr. Raje will be releasing data from a recent study supporting reducing the frequency of bisphosphonates treatments to every three months.

Treating Multiple Myeloma with Immunotherapy

Is there any research about treating myeloma with immunotherapy? In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of SCCA discusses the eradication of chronic lymphocytic leukemia with adoptive T cell therapy. The effects of this treatment against multiple myeloma are currently being studied. Dr. Noopur Raje describes how adoptive t-cell therapy increases T cells and NK (natural killer) cells over time, which fight tumor cells. It ""wakes up"" your immune system and teaches it to fight against myeloma.